Genmab Relies on IDBS’ ActivityBase XE for Analyzing Results from Its Discovery Activities Therapeutic monoclonal antibodies are the fastest growing segment within the pharmaceutical market. Among ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Accio Data, the background screening industry’s leading enterprise platform provider, and Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company ...

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO) Cancer is the second leading cause of death globally. However, by ...

Protecting your data is a lot like your security practices. But legacy applications are no longer sufficient in this evolving digital transformation era. Some say now is the time to move on from ...

Please provide your email address to receive an email when new articles are posted on . Surveillance led to detection of smaller tumors among patients at high risk for pancreatic cancer. Individuals ...

The Bloomberg Philanthropies What Works Cities Certification’s assessment process has been streamlined, in an effort to reduce the barrier to entry for local governments to measure and validate their ...

Genomic newborn screening using whole-genome sequencing identified 1.6% of infants with high-chance, treatable genetic ...

DISA provides employment screening solutions, such as drug and alcohol testing and background verifications, for franchises. A hack at employee screening firm DISA Global Solutions has exposed the ...